abstract |
Described herein are compounds useful in the treatment of disorders characterized by the deposition of amyloid aggregates, as well as pharmaceutical compounds comprising the compounds. In particular, the compounds of the invention are those having the formula (I) reported below: (Wherein the radical has the meaning described in the specification). |